Marisa Fusto

Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia

I. Screpanti, M. Mori, C. Ingallina, 2017, Scientific Reports.

Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation

G. D'offizi, C. Agrati, A. Sacchi, 2022, Clinical Proteomics.

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)

A. d’Arminio Monforte, C. Agrati, E. Nicastri, 2023, eClinicalMedicine.

Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia

C. Agrati, S. Topino, G. Ippolito, 2020, Scientific Reports.

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV

C. Agrati, E. Cimini, C. Castilletti, 2022, Nature Communications.

Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV

A. Antinori, R. Bellagamba, P. Lorenzini, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2 Omicron Variant Neutralization after Third Dose Vaccination in PLWH

A. Antinori, V. Puro, E. Girardi, 2022, Viruses.

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count

C. Agrati, E. Cimini, C. Castilletti, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH

C. Agrati, E. Nicastri, A. Antinori, 2022, Journal of Clinical Medicine.

Declining Prevalence of Human Immunodeficiency Virus (HIV)–Associated Neurocognitive Disorders in Recent Years and Associated Factors in a Large Cohort of Antiretroviral Therapy–Treated Individuals With HIV

A. Antinori, R. Bellagamba, P. Lorenzini, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against SARS-CoV-2 in People Living with HIV (PLWH) Receiving Antiretroviral Therapy (ART) According with Current CD4 T-Lymphocyte Count

C. Agrati, E. Cimini, C. Castilletti, 2021, SSRN Electronic Journal.